Michael A Tsoukas

15PUBLICATIONS
46CO-AUTHORS
Molecular targetsPharmacogenomicsMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 31, 2026
The Effect of Canagliflozin Dose on Renal and Cardiovascular Outcomes in Type 2 Diabetes and High Cardiovascular Risk.

|Feb 02, 2026
Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double-blind, randomised, placebo-controlled cross-over trial.

Luxcia Kugathasan, Michael A Tsoukas, Massimo Nardone

|Jan 12, 2026
A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies.

Alexandra Katz, Aidan Shulkin, Asmaa Housni

|Dec 15, 2025
Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes.

Alessandra Kobayati, Michael A Tsoukas, Natasha Garfield

|Nov 01, 2025
A Pilot Outpatient Assessment of a Fully Closed-Loop Insulin and Pramlintide System.

Madison Odabassian, Michael A Tsoukas, Elisa Cohen

|Oct 27, 2025
Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post-hoc analysis of a double-blinded, randomised, crossover trial.

Melissa-Rosina Pasqua, Michael A Tsoukas, Ahmad Haidar

Pageof 3

Frequent Collaborators

5 joint publications

Melissa-Rosina Pasqua

5 joint publications

Ahmad Haidar

3 joint publications

Jessica Murphy

3 joint publications

Bjorn T Tam